Depression trials in United States
272 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Where
- Atlanta, Baltimore, Birmingham, Boston, Chapel Hill, Cincinnati, East Providence, Evanston, Houston, New Haven, Rochester, Washington D.C.
- Age
- 12 years to 17 years
- People
- 258 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07227454 · EU 2024-518615-19-00 - Phase 1Not yet taking people in United StatesShortened LSD Intervention for Major Depressive Disorder
- Where
- Baltimore
- Age
- 21 years to 70 years
- People
- 10
- Run by
- Johns Hopkins University
See details and how to joinNCT07503002 - Phase 3Taking peopleA Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Where
- Atlanta, Baltimore, Bellevue, Bellflower, Boston, Brooklyn, Bryant, Cary, Chicago, Cincinnati, Clinton, Dallas, Doral, Edmond, Glendale, Hialeah, Houston, Las Vegas, Maitland, Marlton, Miami, Mount Kisco, New York, Oceanside, Oklahoma, Orange, Philadelphia, Riverside, Snellville, Stafford, Tampa, Walnut Creek, Watertown, West Palm Beach
- Age
- 18 years to 74 years
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07573176 - Phase 3Taking peopleA Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression
- Where
- Bellevue, Cape Coral, Cedarhurst, Columbus, Farmington, Marietta, Miami, New York, Orlando, Redlands, Saint Maries, San Diego, Skokie, Snellville, Watertown
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07716098 - Phase 3Taking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Where
- Atlantis, Austin, Baltimore, Beaumont, Bellevue, Birmingham, Boston, Bradenton, Chicago, Decatur, DeSoto, Harlingen, Hollywood, Irvine, Katy, Long Beach, Miami, Naples, Oakland, Omaha, Philadelphia, Phoenix, Provo, Sandy Springs, The Bronx, Troy, Valley Village, Watertown, West Chester, West Palm Beach
- Age
- 18 years to 75 years
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07775300 · EU 2025-522310-24-00 - No phaseTaking peopleEEG-Guided Transcranial Magnetic Stimulation for Adults With Depression
- Where
- Rochester
- Age
- 22 years to 60 years
- People
- 60
- Run by
- Mayo Clinic
See details and how to joinNCT07862205 - Phase 3Taking peopleA Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Where
- Atlanta, Austin, Baltimore, Birmingham, Boston, Chicago, DeSoto, Eden Prairie, Everett, Fort Worth, Gilbert, Glendale, Golden Valley, Houston, Imperial, Jacksonville, Las Vegas, Little Rock, Los Angeles, Maitland, Marietta, Marrero, Naples, New Haven, New Orleans, New York, Oklahoma City, Orange, Philadelphia, Rockville, San Antonio, San Juan Capistrano, Santa Monica, Seattle, Stanford, Tampa, The Bronx, Toms River, Watertown
- Age
- 18 years to 85 years
- People
- 330 worldwide
- Run by
- Cybin IRL Limited
See details and how to joinNCT06793397 · EU 2024-519270-40-00 - Phase 3Taking peopleLong-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Where
- Atlanta, Avon Lake, Bellaire, Boston, Bryant, Cedarhurst, Chino, Cromwell, Dallas, DeSoto, Draper, Edmond, Farmington, Gaithersburg, Glendale, Hollywood, Houston, Huntsville, Irvine, Little Rock, Los Angeles, Maitland, Miami, Miami Gardens, Mount Kisco, New York, Oceanside, O'Fallon, Oklahoma City, Orange, Orlando, Palm Bay, Philadelphia, Pico Rivera, Richmond, Saint Charles, San Diego, San Francisco, San Jose, Stafford, Tampa, The Bronx, The Woodlands, Upland, Watertown
- Age
- 18 years and over
- People
- 850 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT06966401 · EU 2024-519423-24-00 - No phaseEnrolling by invitationVagus Nerve Stimulation (VNS) Electroencephalogram (EEG) Protocol Supplement
- Where
- Stanford
- Age
- 18 years and over
- People
- 12
- Run by
- Stanford University
See details and how to joinNCT07310381 - Phase 2Taking peopleDupilumab in Major Depressive Disorder
- Where
- New York
- Age
- 18 years to 65 years
- People
- 34
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07908563 - Phase 1Taking peopleOpen-Label Psilocybin Study in Transdiagnostic Population
- Where
- New Haven
- Age
- 18 years and over
- People
- 50
- Run by
- Yale University
See details and how to joinNCT06442423 - Phase 1/2Taking peopleSynaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder
- Where
- Belmont
- Age
- 18 years and over
- People
- 100
- Run by
- Mclean Hospital
See details and how to joinNCT07593222 - Phase 2Taking peopleA Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Where
- Austin, Buena Park, Chicago, Chino, Dallas, Jacksonville, Las Vegas, Lemon Grove, Maitland, McKinney, Mephis, Methuen, Miami, New Orleans, New York, Norcross, North Charleston, Orange, Orange City, Orlando, Phoenix, Plano, Provo, Rockville, San Diego, Tampa, Walnut Creek
- Age
- 18 years and over
- People
- 360
- Run by
- Tonix Pharmaceuticals, Inc.
See details and how to joinNCT07621237 - Early phase 1Taking peopleSingle Day of Ultra-accelerated TMS With a Single Dose of NRX-101
- Where
- Belmont
- Age
- 18 years and over
- People
- 30
- Run by
- Mclean Hospital
See details and how to joinNCT07785102 - No phaseTaking peopleDigital Intervention for Physical Activity
- Where
- Auburn
- Age
- 19 years to 40 years
- People
- 50
- Run by
- Auburn University
See details and how to joinNCT07130734 - Phase 2Taking peopleDouble-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Where
- Atlanta, Bellaire, Birmingham, Brooklyn, Charlotte, Chino, Clinton, Cromwell, Decatur, Denver, Encino, Everett, Flowood, Garden Grove, Houston, Jacksonville, Las Vegas, Lemon Grove, Marlton, Miami, Montclair, New York, O'Fallon, Oklahoma City, Orange, Orlando, Palm Bay, Phoenix, Portland, Rogers, Saint Charles, Salt Lake City, San Jose, Tampa, Temecula, Warrenville, Wichita Falls
- Age
- 18 years to 70 years
- People
- 230
- Run by
- Supernus Pharmaceuticals, Inc.
See details and how to joinNCT07226661 - No phaseTaking peopleSAINT® Therapy for Memory Problems in Older Adults With Treatment-Resistant Depression
- Where
- Costa Mesa
- Age
- 65 years and over
- People
- 20
- Run by
- BrainHealth Solutions, Inc.
See details and how to joinNCT07876908 - Phase 2Taking peopleA Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
- Where
- Jacksonville
- Age
- 18 years to 65 years
- People
- 180
- Run by
- Alkermes, Inc.
See details and how to joinNCT07901179 - No phaseTaking peopleTracking Response to Antidepressants in Advance of Investigational Trials
- Where
- Watertown
- Age
- 18 years and over
- People
- 400
- Run by
- Adams Clinical
See details and how to joinNCT04748276 - Phase 2Taking peopleCognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
- Where
- Boston
- Age
- 25 years to 50 years
- People
- 100
- Run by
- Massachusetts General Hospital
See details and how to joinNCT06136546 - No phaseTaking peopleUnderstanding the Neural Underpinnings of Risk-Taking Behavior in Psychiatric Disease
- Where
- San Francisco
- Age
- 18 years and over
- People
- 10
- Run by
- University of California, San Francisco
See details and how to joinNCT07896343 - No phaseTaking peopleCharacterization and Treatment of Adolescent Depression
- Where
- Bethesda, Denver, Los Angeles
- Age
- 11 years to 25 years
- People
- 4,100
- Run by
- National Institute of Mental Health (NIMH)
See details and how to joinNCT03388606 - Phase 2Taking peopleStudy of ALTO-300 in MDD
- Where
- Albuquerque, Allentown, Austin, Bellflower, Blackfoot, Boise, Carlsbad, Chicago, Cincinnati, Clermont, Clinton, Colorado Springs, Conroe, Creve Couer, Dallas, Denver, Evergreen, Fairfax, Fayetteville, Fort Worth, Glendale, Hattiesburg, Hickory, Houston, Jackson, Lafayette, Las Vegas, Los Angeles, Mankato, Marrero, Mather, Media, Miami Gardens, Miami Lakes, Minneapolis, Mission Viejo, Missouri City, Monroe, Moorpark, Moosic, New York, Norwalk, Okeechobee, Oklahoma City, Omaha, Phoenix, Plano, Provo, Richmond, Roanoke, Rochester, Rogers, Rose Hill, San Marcos, Savannah, Snellville, Staten Island, Stephenville, St Louis, Stone Mountain, Tampa, Temecula, West Palm Beach, Wichita, Winston-Salem, Worcester, Yuma
- Age
- 18 years to 70 years
- People
- 325
- Run by
- Alto Neuroscience
See details and how to joinNCT05922878 - Phase 2Taking peopleALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Where
- Albany, Amherst, Annapolis, Ann Arbor, Austin, Baltimore, Bloomfield Hills, Bryan, Cary, Cedarhurst, Charlotte, Chino, Cincinnati, Dallas, Dayton, Dothan, East Providence, Fairfax, Fort Worth, Galveston, Garfield Heights, Grand Rapids, Houston, Indianapolis, Irving, La Jolla, Lewiston, Los Angeles, Marietta, Naperville, North Myrtle Beach, Oakland, Oceanside, Palo Alto, Phoenix, Pikesville, Plano, Rockville, Sacramento, Saint Augustine, San Diego, San Jose, Savannah, Seattle, Snellville, South Charleston, St Louis, Syracuse, Toms River, Valley Village, Wilton, Worcester
- Age
- 18 years to 75 years
- People
- 178 worldwide
- Run by
- Alto Neuroscience
See details and how to joinNCT07553637 - Phase 2Not yet taking people in United StatesPsilocybin for Depression in Veterans
- Where
- Minneapolis, Salt Lake City, San Diego, San Francisco
- Age
- 18 years to 70 years
- People
- 150
- Run by
- VA Office of Research and Development
See details and how to joinNCT07895134